Research and Development Costs of New Drugs

被引：1

作者：

Dierynck, Bart ^{[1
]}

Joos, Philip ^{[1
]}

机构：

[1] Tilburg Univ, Tilburg, Netherlands

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 324卷 / 05期

关键词：

D O I：

10.1001/jama.2020.8642

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：516 / +

页数：5

共 50 条

[31] REPRESENTATIVE COSTS OF DOING RESEARCH AND DEVELOPMENT [J].

GAMBS, GC .

RESEARCH MANAGEMENT, 1959, 2 (01) :33-43

[32] NEW DRUG DEVELOPMENT COSTS [J].

FELDMANN, EG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (02) :1-1

[33] Assessing Pharmaceutical Research and Development Costs [J].

van der Gronde, Toon ;

Pieters, Toine .

JAMA INTERNAL MEDICINE, 2018, 178 (04) :587-+

[34] RESEARCH AND DEVELOPMENT COSTS AS A BARRIER TO ENTRY [J].

MUELLER, DC ;

TILTON, JE .

CANADIAN JOURNAL OF ECONOMICS, 1969, 2 (04) :570-579

[35] RESEARCH FOR NEW ANTICHAGASIC DRUGS [J].

MESTER, B ;

CLARAMUNT, RM ;

ELGUERO, J ;

ATIENZA, J ;

BARRIO, AG ;

ESCARIO, JA .

CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (08) :1990-1993

[36] NEW DRUGS FROM RESEARCH [J].

FREUND, J .

DRUG & COSMETIC INDUSTRY, 1980, 127 (01) :54-&

[37] EXPENSIVE NEW DRUGS AND THE COSTS OF AVOIDING A SMALL RISK [J].

LEONARD, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (18) :1008-1008

[38] ARE THERE CONSEQUENCES TO BE DRAWN FROM CLINICAL DEPRESSION RESEARCH FOR THE DEVELOPMENT OF NEW ANTIDEPRESSANT DRUGS [J].

MATUSSEK, N .

PHARMACOPSYCHIATRY, 1989, 22 (01) :1-2

[39] The costs of new drugs compared to current standard treatment [J].

Ujeyl, Mariam ;

Schlegel, Claudia ;

Gundert-Remy, Ursula .

ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2013, 107 (07) :461-467

[40] Recent approaches in the drug research and development of novel antimalarial drugs with new targets [J].

Chinnappanna, Naveen Kumar Reddy ;

Yennam, Gopi ;

Chaitanya, Chaitanya Budagam Haima Naga Venkata ;

Pottathil, Shinu ;

Borah, Pobitra ;

Venugopala, Katharigatta N. ;

Deb, Pran Kishore ;

Mailavaram, Raghu Prasad .

ACTA PHARMACEUTICA, 2023, 73 (01) :1-27

← 1 2 3 4 5 →